Results From Oxford University's Human Trial Of Coronavirus Vaccine Could Arrive In June; Where Inovio, Moderna Stand

The University of Oxford, which is partnering with large-cap pharma AstraZeneca plc (NYSE: AZN) to develop a vaccine for SARS-CoV-2, could lead the pack in advancing its vaccine candidate to the next stage.The university is one of the eight companies and institutions that have advanced their candidates to human testing, according to the latest World…

Nightmare at Sea Ends in Death for Some Cruise-Ship Workers

(Bloomberg) — Lauren Carrick and fiance Joe Harrison haven’t had a good night’s sleep in weeks. The two dancers on Celebrity Cruises’ Infinity say being held aboard ships for almost two months has left them emotionally drained.“I cried all day,” said Carrick, 29. “We need to have alcohol to sleep — that’s how bad it…

Global Markets: Stocks rally falters as virus and trade nerves linger

Europe’s share markets, bond yields and the euro all inched higher on Tuesday, as mildly reassuring signals from China’s economy helped limit worries about a potential second wave of coronavirus infections. The mood was decidedly fragile, with five new virus cases in Wuhan – the original epicentre of the outbreak – renewed trade tensions and…

Goldman Says Stocks Due for 18% Drop After Rally Driven by FOMO

(Bloomberg) — In the equity market, fear of missing out seems to be overshadowing fear of all that’s wrong with the economy. Goldman Sachs Group Inc. says pessimism will soon get the upper hand and send the S&P 500 Index down almost 20% in the next three months.Fiscal and monetary support over the past few…

Gilead’s Remdesivir Will Be Distributed By State Health Departments

The US Department of Health has now announced the allocation plan for Gilead’s (GILD) Covid-19 treatment remdesivir, revealing that states rather than federal government will be in charge of distribution.The donated doses of the treatment, which received an Emergency Use Authorization (EUA) from the FDA on May 1, will be used to treat hospitalized COVID-19…

Billionaire Bill Ackman Picks up These 2 Stocks as Markets Recover

Billionaire Bill Ackman is growing increasingly optimistic. After warning “hell is coming” back in March, the highly-respected stock picker has started singing a different tune, arguing that the possibility of hydroxychloroquine and antibiotic treatments, the ramping up of antibody tests, government stimulus and low interest rates are encouraging signs.It’s no wonder market watchers track Ackman’s…